Bluefin Capital Management, LLC Gsk PLC Transaction History

Bluefin Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$42.05 - $47.77 $2,523 - $2,866	60 Added 1.02%	5,960 $261,000
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $132,759 - $157,542	-3,300 Reduced 35.87%	5,900 $257,000
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $35,769 - $41,685	-920 Reduced 9.09%	9,200 $406,000
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $392,554 - $436,779	10,120 New	10,120 $387,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.